Home/Filings/4/0001181431-12-007544
4//SEC Filing

WELCH JAMES H 4

Accession 0001181431-12-007544

CIK 0001427925other

Filed

Feb 8, 7:00 PM ET

Accepted

Feb 9, 7:53 PM ET

Size

5.6 KB

Accession

0001181431-12-007544

Insider Transaction Report

Form 4
Period: 2012-02-07
WELCH JAMES H
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2012-02-07+72,57972,579 total
    Exercise: $3.39From: 2013-02-07Exp: 2022-02-06Common Stock (72,579 underlying)
Footnotes (3)
  • [F1]Issued pursuant to the 2011 Equity Incentive Plan.
  • [F2]The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the Vesting Commencement Date (February 7, 2012) and the remaining shares subject to the stock option vest on an equal monthly basis over the following 36 months.
  • [F3]The shares have double-trigger acceleration on a change of control.

Issuer

ACELRX PHARMACEUTICALS INC

CIK 0001427925

Entity typeother

Related Parties

1
  • filerCIK 0001190278

Filing Metadata

Form type
4
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 7:53 PM ET
Size
5.6 KB